Vijaya Diagnostic Centre Limited (VIJAYA)
Press Release on Q1 Un-audited financial results for FY 27
Press Release - Q1FY27
- Revenue 2.31bn +22.8% y-y; EBITDA 985.4mn +34.0% y-y; EBITDA margin 42.7% (+356 bps); PAT 531.0mn +37.6% y-y
- Volume growth of 16.5% y-y with total tests at 4.59mn
- Network expansion with new hub centres in Hyderabad and Bengaluru commissioned in Q1 FY27
- Advanced imaging technologies introduced including first wide bore 3T Omega MRI in Karnataka
- Focus on leadership team strengthening and disciplined execution for sustainable scaling
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 VIJAYA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add VIJAYA to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Vijaya Diagnostic Centre Limited
Important.
The summary above is generated automatically from Vijaya Diagnostic Centre Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.